NE Field Diagnostics Ltd. Their innovative approach eliminates the need for forced breathing maneuvers, making it ideal for individuals with respiratory symptoms and even small children. This non-invasive testing method is completely automated and can be performed on individuals of all ages, including neonates.

Utilizing their patented device, method, and algorithm, NE Field Diagnostics measures the most accurate parameter for airway obstructions, known as Airway Resistance (Raw), which is twice as sensitive as FEV1 (forced expiratory volume in 1 sec). The brand's aim is to provide a reliable solution for home monitoring of chronic respiratory diseases like COPD and Asthma, ultimately preventing exacerbation and unnecessary hospitalization. NE Field Diagnostics has achieved significant milestones, including establishing a subsidiary in China, obtaining a patent pending, conducting successful animal trials, and forming a scientific advisory board.

Their highly accomplished team consists of experienced professionals in engineering, pulmonology, healthcare management, algorithms, and electronics. With a focus on reducing healthcare costs and improving patient outcomes, NE Field Diagnostics is revolutionizing lung function testing and monitoring